![Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Frontline Gastroenterology Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Frontline Gastroenterology](https://fg.bmj.com/content/flgastro/5/3/211/F1.large.jpg)
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Frontline Gastroenterology
![Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis](https://www.frontiersin.org/files/Articles/774079/fmed-08-774079-HTML/image_m/fmed-08-774079-g001.jpg)
Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
![Non-invasive scoring systems for predicting NASH in Japan: evidences from Japan Study Group of NAFLD Non-invasive scoring systems for predicting NASH in Japan: evidences from Japan Study Group of NAFLD](https://www.oatext.com/img/Non-invasive-3.jpg)
Non-invasive scoring systems for predicting NASH in Japan: evidences from Japan Study Group of NAFLD
![Frontiers | Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study Frontiers | Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study](https://www.frontiersin.org/files/Articles/599339/fendo-12-599339-HTML/image_m/fendo-12-599339-t004.jpg)
Frontiers | Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study
![Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/355d73f6-ab09-4fef-b4e9-0083ef9bb5d3/hepr13688-fig-0001-m.jpg)
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library
![Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease - ScienceDirect Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589555919300618-ga1.jpg)
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease - ScienceDirect
![JCM | Free Full-Text | Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting JCM | Free Full-Text | Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting](https://pub.mdpi-res.com/jcm/jcm-09-02851/article_deploy/html/images/jcm-09-02851-g001-550.jpg?1599128008)
JCM | Free Full-Text | Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting
![Table 1 from The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease | Semantic Scholar Table 1 from The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b90b27221a866f1a2786f6986421c23611d0efdf/3-Table1-1.png)
Table 1 from The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease | Semantic Scholar
![American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice](https://www.endocrinepractice.org/cms/attachment/3a8cc399-770d-4b1c-bb4f-90c14911a710/gr1.jpg)
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice
![Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches](https://pub.mdpi-res.com/diagnostics/diagnostics-12-00407/article_deploy/html/images/diagnostics-12-00407-g001-550.jpg?1644571167)